UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Sound waves could supercharge chemo against tough pancreatic cancer
Disease control OngoingThis study tests a new method called sonoporation, which uses ultrasound and tiny gas bubbles to help chemotherapy drugs get into cancer cells more effectively. About 120 adults with advanced pancreatic cancer will receive either standard chemotherapy alone or chemotherapy plus s…
Matched conditions: UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Flemming Forsberg • Aim: Disease control
Last updated May 26, 2026 09:07 UTC
-
New combo targets Hard-to-Treat pancreatic cancer
Disease control TerminatedThis early-stage trial tests a new drug called CA-4948 added to standard chemotherapy for people with pancreatic cancer that has spread or can't be removed. The goal is to find the safest dose and see if the combination can shrink tumors or stop them from growing. About 43 adults…
Matched conditions: UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Personalized cell therapy trial for advanced cancers withdrawn before enrollment
Disease control TerminatedThis early-stage trial aimed to test the safety and effectiveness of STIL101, a personalized cell therapy made from a patient's own tumor-fighting T cells, for several advanced cancers including pancreatic, colorectal, kidney, cervical, and melanoma. The treatment involved collec…
Matched conditions: UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New drug combo shows promise for Hard-to-Treat pancreatic cancer
Disease control OngoingThis study tests whether a combination of two drugs, lenvatinib and pembrolizumab, can help control advanced pancreatic cancer that cannot be removed by surgery. About 28 adults whose cancer has not worsened after initial treatment will receive these drugs as maintenance therapy.…
Matched conditions: UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Desperate patients get early access to experimental cachexia drug
Symptom relief NO_LONGER_AVAILABLEThis program gives seriously ill adults with advanced pancreatic cancer and severe weight loss (cachexia) early access to the experimental drug mifomelatide. It is for patients who have no other treatment options for their weight loss and cannot join current clinical trials. Doct…
Matched conditions: UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
Sponsor: Endevica Bio • Aim: Symptom relief
Last updated May 26, 2026 08:55 UTC